industries: Pharma & Biotech

The Inflation Reduction Act (IRA) represents a significant transformation within the US healthcare landscape. While focused on reducing prescription drug costs for consumers, which rose by about 31% between 2016 and 2022, the Act presents a fundamental challenge to the established operating model of pharmaceutical companies. The IRA functions as a catalyst, prompting a necessary… Read More

The imperative for effective decision-making in the pharmaceutical industry has never been more pronounced. Pharmaceutical companies are under considerable pressure to innovate and demonstrate value with the healthcare sector’s shifting focus towards outcomes and the patient experience. Advanced analytics applied to real-world evidence (RWE) has emerged as a critical driver for decision-making in this environment…. Read More